Pharma Journalist -

DKSH Business Unit Healthcare has expanded its prescription drug business in South Korea through a new strategic partnership with Novartis, adding the hypertension medicines Diovan and…
Read More...

Ember LifeSciences has entered into a capital and business alliance with Alfresa Corporation to strengthen pharmaceutical cold chain logistics in Japan and expand access to advanced…
Read More...

Shionogi has announced the US availability of XOCOVA (ensitrelvir), an oral antiviral approved by the US Food and Drug Administration (FDA) for post-exposure prophylaxis (PEP) of…
Read More...

As investment, innovation, and dealmaking continue to reshape the antibody-drug conjugate (ADC) landscape, Michael Torres, Chief Executive Officer of CrossBridge Bio, has shared his…
Read More...

Are We Asking the Right Questions in COPD Drug Development? As the industry looks beyond traditional measures such as lung function and exacerbations, a new question is emerging: What…
Read More...

argenx has agreed to acquire Forte Biosciences for approximately $2.2 billion in cash, strengthening its immunology pipeline with a promising experimental therapy for autoimmune…
Read More...

BioMarin Pharmaceutical and the n-Lorem Foundation have entered a strategic collaboration to develop what could become the first disease-modifying treatment for ReNU syndrome, a rare…
Read More...

Pfizer Japan Inc. and Eisai Co., Ltd. have announced a new collaboration to co-promote the migraine treatment Nurtec OD Tablet 75mg (rimegepant sulfate hydrate) across Japan beginning…
Read More...

Biointron Biological USA Inc. has introduced RushData, a new integrated service platform designed to accelerate antibody discovery by providing rapid experimental validation for…
Read More...

Outlook Therapeutics has secured U.S. Food and Drug Administration (FDA) approval for LYTENAVA™ (bevacizumab-vikg), making it the first and only FDA-approved ophthalmic formulation of…
Read More...